CtrlK
Ginkgo Bioworks Holdings
DNA58
$6.46arrow_drop_down2.85%-$0.19
High Growth
DNA58
$6.46
arrow_drop_down2.85%Performance History
There's no data available for performance history chart
| Key Stats | |
|---|---|
| Open | $6.77 |
| Prev. Close | $6.65 |
| EPS | -10.54 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $380.12M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 6.33 | 6.87 |
| 52 Week Range | 5.26 | 75.20 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
There's no data available for Analyst Forecast
Period: -
• Predicted: -Analyst Ratings
There's no data available for Analyst Ratings
Last updated: -
• Total: -About Ginkgo Bioworks Holdings (DNA)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Jason Kelly
- Headquarters
- Boston
- Employees
- 1292
- Exchange
- NYSE
Keep an eye on Ginkgo Bioworks Holdings
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Ginkgo Bioworks Holdings's (DNA) price per share?
The current price per share for Ginkgo Bioworks Holdings (DNA) is $6.46. The stock has seen a price change of -$0.19 recently, indicating a -2.86% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Ginkgo Bioworks Holdings (DNA)?
For Ginkgo Bioworks Holdings (DNA), the 52-week high is $75.2, which is 1.06K% from the current price. The 52-week low is $5.26, the current price is 22.81% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Ginkgo Bioworks Holdings (DNA) a growth stock?
Ginkgo Bioworks Holdings (DNA) has shown an average price growth of -1.65% over the past three years. It has received a score of 96 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Ginkgo Bioworks Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Ginkgo Bioworks Holdings (DNA) stock price performance year to date (YTD)?
As of the latest data, Ginkgo Bioworks Holdings (DNA) has a year-to-date price change of -34.22%. Over the past month, the stock has experienced a price change of -47.56%. Over the last three months, the change has been -37.46%. Over the past six months, the figure is 3.03%.
help
Is Ginkgo Bioworks Holdings (DNA) a profitable company?
Ginkgo Bioworks Holdings (DNA) has a net income of -$547.03M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 83.02% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -214.69% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $227.04M, although specific revenue growth data is currently not available. The gross profit is $188.49M. Operating income is noted at -$559.76M. Furthermore, the EBITDA is -$415.7M.
help
What is the market capitalization of Ginkgo Bioworks Holdings (DNA)?
Ginkgo Bioworks Holdings (DNA) has a market capitalization of $380.12M. The average daily trading volume is 6.52, indicating the stock's liquidity and investor engagement.